Efficiency of PRP on Acellular Dermal Matrix Application in the Treatment of Multiple Adjacent Gingival Recessions
PRP
Efficiency of Platelet-Rich Plasma (PRP) on Acellular Dermal Matrix Application With Coronally Advanced Flap in the Treatment of Multiple Adjacent Gingival Recessions:a Double-masked Randomized Controlled Clinical Trial
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The aim of this study was to evaluate the effectiveness of platelet rich plasma (PRP) combined with coronally advanced flap plus acellular dermal matrix application (CAF+ADM) in the treatment of multiple adjacent gingival recessions (MAGRs). 12 patients with 84 Miller Class I or II recession defects were participated. Sites were randomly assigned into CAF+ADM+PRP or CAF+ADM groups. Gingival recession depth (GRD), recession width (GRW), width of keratinized tissue (WKT), creeping attachment (CRA), root coverage (RC) as well as plaque index, gingival index, probing depth (PD), and clinical attachment level (CAL) were recorded at baseline and 3rd,6th and 12th months postoperatively. The data were analyzed statistically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2008
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2011
CompletedFirst Submitted
Initial submission to the registry
February 2, 2017
CompletedFirst Posted
Study publicly available on registry
February 6, 2017
CompletedFebruary 8, 2017
January 1, 2017
3 years
February 2, 2017
February 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Root coverage (RC)
The percentage of root coverage (RC) was calculated as (\[GRD preoperation - GRD postoperation\] / GRD preoperation) x 100%.
The change in RC at 3rd month to 12th month
Secondary Outcomes (6)
Gingival recession depth (GRD)
Baseline, 3,6 and 12 months after periodontal surgery
recession width (GRW)
Baseline, 3,6 and 12 months after periodontal surgery
width of keratinized tissue (WKT)
Baseline, 3,6 and 12 months after periodontal surgery
plaque index(PI)
Baseline, 3,6 and 12 months after periodontal surgery
gingival index
Baseline, 3,6 and 12 months after periodontal surgery
- +1 more secondary outcomes
Study Arms (2)
CAF+ADM+PRP
EXPERIMENTALSurgery will include Coronally advanced flap(CAF) plus acellular dermal matrix (ADM) combined with platelet rich plasma (PRP)
CAF+ADM
ACTIVE COMPARATORSurgery will include only Coronally advanced flap CAF technique including ADM placement without PRP
Interventions
CAF+ADM+PRP group treated with coronally advanced flap technique including ADM placement, In CAF+ADM+PRP group, ADM was hydrated in the platelet-poor plasma (PPP) and the PRP was applied to surgical sites prior to final suturing.
CAF+ADM group treated with coronally advanced flap technique including ADM placement without PRP application
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of the presence of at least three multiple adjacent Miller class I or II recessions on both sides of the same maxillary or mandibular arch
- must be able to have 2 mm-high keratinized tissue apical to the root exposures;
- must be able to have no systemic diseases that could influence the outcome of the therapy;
- must be able to have a full-mouth plaque score of 20% (O'Leary et al. 1972);
- must be non-smoker;
- must be not pregnant.
You may not qualify if:
- debilitating systemic or infectious diseases (human immunodeficiency virus or hepatitis) -- -any disease that significantly affects the periodontium;
- known allergy to any of the materials used in the study; requirement for antibiotic prophylaxis;
- taking medications known to interfere with periodontal health and healing not detectable cemento-enamel junction (CEJ);
- restorations or caries at the recession site;
- failure to maintain an oral hygiene level ≥80% plaque-free surfaces; pregnancy or lactation; use of tobacco products; alcohol abuse;
- a previous periodontal surgery at the recession site and failure to complete the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Shepherd N, Greenwell H, Hill M, Vidal R, Scheetz JP. Root coverage using acellular dermal matrix and comparing a coronally positioned tunnel with and without platelet-rich plasma: a pilot study in humans. J Periodontol. 2009 Mar;80(3):397-404. doi: 10.1902/jop.2009.080438.
PMID: 19254123BACKGROUNDCetiner D, Gokalp Kalabay P, Ozdemir B, Cankaya ZT. Efficiency of platelet-rich plasma on acellular dermal matrix application with coronally advanced flap in the treatment of multiple adjacent gingival recessions: A randomized controlled clinical trial. J Dent Sci. 2018 Sep;13(3):198-206. doi: 10.1016/j.jds.2017.11.002. Epub 2018 Feb 3.
PMID: 30895121DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pelin Gokalp
Gazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2017
First Posted
February 6, 2017
Study Start
July 1, 2008
Primary Completion
June 20, 2011
Study Completion
June 20, 2011
Last Updated
February 8, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share
When needed data can be shared via email.